Dr. Regev is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
720 Eskenazi Ave
Indianapolis, IN 46202Phone+1 317-880-8329Fax+1 305-243-8470- Is this information wrong?
Education & Training
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1988
Certifications & Licensure
IN State Medical License 2007 - 2025
FL State Medical License 2001 - 2007
Publications & Presentations
PubMed
- Correction to: Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative.Eric B Cohen, Meenal Patwardhan, Ritu Raheja, David H Alpers, Raul J Andrade, Mark I Avigan, James H Lewis, Don C Rockey, Francis Chui, Alexandru M Iacob, Camila C Lin...> ;Drug Safety. 2024 May 1
- Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomod...Eric B Cohen, Arie Regev, Anju Garg, Adrian M Di Bisceglie, James H Lewis, John M Vierling, Judith Hey-Hadavi, Klaudia Steplewski, Anna Fettiplace, Chunlin L Chen, Non...> ;Drug Safety. 2024 Apr 1
- Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study.Amita Datta-Mannan, Arie Regev, David E Coutant, Andrew J Dropsey, Joanne Foster, Spencer Jones, Josh Poorbaugh, Carsten Schmitz, Evan Wang, Michael E Woodman> ;Clinical Pharmacology and Therapeutics. 2024 May 1
- Join now to see all
Other
- Diagnosis and management of cystic lesions of the liverRegev A, Reddy KR
http://www.uptodate.com/contents/diagnosis-and-management-of-cystic-lesions-of-the-liver
UpToDate, Wolters Kluwer Health - 2013-03-22
Press Mentions
Consensus: Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Patients with Nonalcoholic SteatohepatitisFebruary 13th, 2020
Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisFebruary 14th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
